Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice
Abstract
•Adeno-associated virus (AAV)-mediated gene therapy can correct Abcb4 deficiency (PFIC3) in mice.•By restoring phospholipid transport to bile, cholestasis and liver damage were strongly reduced.•Stable transgene expression resulted in long-term correction of the phenotype (26 weeks).•Hepatic transgene persistence was achieved by sufficiently reducing hepatocyte proliferation. Background & AimsProgressive familial intrahepatic cholestasis type 3...
Paper Details
Title
Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice
Published Date
Jul 1, 2019
Journal
Volume
71
Issue
1
Pages
153 - 162
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History